US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 7.0300
  • -0.4800-6.39%
Close Jan 8 16:00 ET
73.56MMarket Cap0.07P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
5.51%249K
0
0
-89.34%1.92M
-36.27%571K
-98.42%236K
-37.75%643K
-59.51%475K
234.40%18.05M
309.13%896K
Operating revenue
5.51%249K
--0
--0
-89.34%1.92M
-36.27%571K
-98.42%236K
-37.75%643K
-59.51%475K
234.40%18.05M
309.13%896K
Cost of revenue
-389.07%-714K
-51.55%343K
-114.52%-80K
-62.61%1.28M
-135.65%-221K
-53.22%247K
-54.82%708K
-23.47%551K
130.32%3.43M
46.23%620K
Gross profit
8,854.55%963K
-427.69%-343K
205.26%80K
-95.62%640K
186.96%792K
-100.08%-11K
87.83%-65K
-116.78%-76K
274.12%14.62M
234.63%276K
Operating expense
269.72%13.82M
28.85%9.13M
-39.09%5.31M
-53.74%24.08M
-50.25%4.54M
-63.79%3.74M
-37.27%7.09M
-59.09%8.72M
-39.50%52.06M
-48.58%9.13M
Selling and administrative expenses
72.13%4.29M
86.57%4.53M
17.91%3.19M
-50.27%10.3M
-9.56%2.68M
-24.18%2.49M
-12.82%2.43M
-76.82%2.71M
-16.01%20.71M
-50.53%2.96M
-Selling and marketing expense
----
200.00%21K
-46.15%7K
-56.58%33K
----
----
-50.00%7K
-69.77%13K
-95.41%76K
-98.04%12K
-General and administrative expense
72.13%4.29M
86.24%4.51M
18.22%3.19M
-50.24%10.27M
-10.32%2.64M
-24.04%2.49M
-12.64%2.42M
-76.85%2.7M
-10.29%20.64M
-45.10%2.95M
Research and development costs
663.65%9.54M
-1.22%4.6M
-64.78%2.12M
-55.97%13.78M
-69.75%1.87M
-82.26%1.25M
-45.26%4.66M
-37.31%6.01M
-47.68%31.31M
-46.38%6.17M
Depreciation amortization depletion
----
----
----
--0
----
----
----
----
-97.55%38K
--0
-Depreciation and amortization
----
----
----
--0
----
----
----
----
-97.55%38K
--0
Operating profit
-242.96%-12.86M
-32.48%-9.47M
40.53%-5.23M
37.38%-23.44M
57.64%-3.75M
-191.58%-3.75M
39.55%-7.15M
57.84%-8.79M
54.42%-37.44M
50.70%-8.86M
Net non-operating interest income expense
162.07%964K
204.32%1.04M
110.54%100K
18.06%-3.42M
108.54%81K
-72.94%-1.55M
13.69%-996K
18.82%-949K
-74.40%-4.17M
19.85%-949K
Non-operating interest income
----
----
--100K
----
----
----
----
----
----
----
Non-operating interest expense
----
----
----
-18.06%3.42M
----
----
----
-18.82%949K
74.40%4.17M
-19.85%949K
Total other finance cost
-162.07%-964K
-204.32%-1.04M
----
----
----
--1.55M
--996K
----
----
----
Other net income (expense)
41,972.29%34.92M
267,357.50%106.9M
-56,285.44%-116.15M
-23,245.00%-4.67M
-4.51M
83K
-40K
-930.00%-206K
0.00%-20K
0
Gain on sale of security
34,825.00%34.93M
267,615.00%107.01M
-44,008.89%-79.4M
---720K
---600K
--100K
---40K
---180K
----
----
Special income (charges)
--0
---103K
---36.76M
---3.91M
---3.91M
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--0
--0
--9.22M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
----
----
----
--3.91M
----
----
----
----
--0
----
-Less:Other special charges
----
--103K
--27.54M
----
----
----
----
----
----
----
Other non- operating income (expenses)
70.59%-5K
----
----
-110.00%-42K
--0
---17K
----
-30.00%-26K
0.00%-20K
--0
Income before tax
541.05%23.02M
1,302.91%98.47M
-1,119.29%-121.28M
24.26%-31.53M
16.60%-8.18M
-263.28%-5.22M
36.94%-8.19M
54.87%-9.95M
50.76%-41.63M
48.80%-9.8M
Income tax
-275.00%-14K
0.00%7K
-12.50%7K
-50.00%14K
-212.50%-9K
60.00%8K
40.00%7K
-11.11%8K
114.29%28K
150.00%8K
Net income
540.65%23.04M
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
Net income continuous Operations
540.65%23.04M
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.61%-41.66M
48.71%-9.81M
Minority interest income
Net income attributable to the parent company
540.65%23.04M
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
Preferred stock dividends
Other preferred stock dividends
17.58M
94.11M
Net income attributable to common stockholders
204.48%5.46M
153.14%4.35M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
Basic earnings per share
103.65%0.98
817.97%1.01K
30.88%-141
89.28%-114
95.92%-10.1878
-132.88%-26.83
57.51%-140.73
63.83%-204
55.49%-1.06K
46.16%-249.4
Diluted earnings per share
89.45%-2.83
-2,299.49%-3.38K
30.88%-141
89.28%-114
95.92%-10.1878
-132.88%-26.83
57.51%-140.73
63.83%-204
55.49%-1.06K
46.16%-249.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 5.51%249K 0 0 -89.34%1.92M -36.27%571K -98.42%236K -37.75%643K -59.51%475K 234.40%18.05M 309.13%896K
Operating revenue 5.51%249K --0 --0 -89.34%1.92M -36.27%571K -98.42%236K -37.75%643K -59.51%475K 234.40%18.05M 309.13%896K
Cost of revenue -389.07%-714K -51.55%343K -114.52%-80K -62.61%1.28M -135.65%-221K -53.22%247K -54.82%708K -23.47%551K 130.32%3.43M 46.23%620K
Gross profit 8,854.55%963K -427.69%-343K 205.26%80K -95.62%640K 186.96%792K -100.08%-11K 87.83%-65K -116.78%-76K 274.12%14.62M 234.63%276K
Operating expense 269.72%13.82M 28.85%9.13M -39.09%5.31M -53.74%24.08M -50.25%4.54M -63.79%3.74M -37.27%7.09M -59.09%8.72M -39.50%52.06M -48.58%9.13M
Selling and administrative expenses 72.13%4.29M 86.57%4.53M 17.91%3.19M -50.27%10.3M -9.56%2.68M -24.18%2.49M -12.82%2.43M -76.82%2.71M -16.01%20.71M -50.53%2.96M
-Selling and marketing expense ---- 200.00%21K -46.15%7K -56.58%33K ---- ---- -50.00%7K -69.77%13K -95.41%76K -98.04%12K
-General and administrative expense 72.13%4.29M 86.24%4.51M 18.22%3.19M -50.24%10.27M -10.32%2.64M -24.04%2.49M -12.64%2.42M -76.85%2.7M -10.29%20.64M -45.10%2.95M
Research and development costs 663.65%9.54M -1.22%4.6M -64.78%2.12M -55.97%13.78M -69.75%1.87M -82.26%1.25M -45.26%4.66M -37.31%6.01M -47.68%31.31M -46.38%6.17M
Depreciation amortization depletion ---- ---- ---- --0 ---- ---- ---- ---- -97.55%38K --0
-Depreciation and amortization ---- ---- ---- --0 ---- ---- ---- ---- -97.55%38K --0
Operating profit -242.96%-12.86M -32.48%-9.47M 40.53%-5.23M 37.38%-23.44M 57.64%-3.75M -191.58%-3.75M 39.55%-7.15M 57.84%-8.79M 54.42%-37.44M 50.70%-8.86M
Net non-operating interest income expense 162.07%964K 204.32%1.04M 110.54%100K 18.06%-3.42M 108.54%81K -72.94%-1.55M 13.69%-996K 18.82%-949K -74.40%-4.17M 19.85%-949K
Non-operating interest income ---- ---- --100K ---- ---- ---- ---- ---- ---- ----
Non-operating interest expense ---- ---- ---- -18.06%3.42M ---- ---- ---- -18.82%949K 74.40%4.17M -19.85%949K
Total other finance cost -162.07%-964K -204.32%-1.04M ---- ---- ---- --1.55M --996K ---- ---- ----
Other net income (expense) 41,972.29%34.92M 267,357.50%106.9M -56,285.44%-116.15M -23,245.00%-4.67M -4.51M 83K -40K -930.00%-206K 0.00%-20K 0
Gain on sale of security 34,825.00%34.93M 267,615.00%107.01M -44,008.89%-79.4M ---720K ---600K --100K ---40K ---180K ---- ----
Special income (charges) --0 ---103K ---36.76M ---3.91M ---3.91M --0 --0 --0 --0 ----
-Less：Restructuring and merger&acquisition --0 --0 --9.22M ---- ---- --0 --0 --0 ---- ----
-Less:Impairment of capital assets ---- ---- ---- --3.91M ---- ---- ---- ---- --0 ----
-Less:Other special charges ---- --103K --27.54M ---- ---- ---- ---- ---- ---- ----
Other non- operating income (expenses) 70.59%-5K ---- ---- -110.00%-42K --0 ---17K ---- -30.00%-26K 0.00%-20K --0
Income before tax 541.05%23.02M 1,302.91%98.47M -1,119.29%-121.28M 24.26%-31.53M 16.60%-8.18M -263.28%-5.22M 36.94%-8.19M 54.87%-9.95M 50.76%-41.63M 48.80%-9.8M
Income tax -275.00%-14K 0.00%7K -12.50%7K -50.00%14K -212.50%-9K 60.00%8K 40.00%7K -11.11%8K 114.29%28K 150.00%8K
Net income 540.65%23.04M 1,301.79%98.46M -1,118.38%-121.29M 24.28%-31.54M 16.75%-8.17M -263.78%-5.23M 36.91%-8.19M 54.85%-9.96M 50.63%-41.66M 48.89%-9.81M
Net income continuous Operations 540.65%23.04M 1,301.79%98.46M -1,118.38%-121.29M 24.28%-31.54M 16.75%-8.17M -263.78%-5.23M 36.91%-8.19M 54.85%-9.96M 50.61%-41.66M 48.71%-9.81M
Minority interest income
Net income attributable to the parent company 540.65%23.04M 1,301.79%98.46M -1,118.38%-121.29M 24.28%-31.54M 16.75%-8.17M -263.78%-5.23M 36.91%-8.19M 54.85%-9.96M 50.63%-41.66M 48.89%-9.81M
Preferred stock dividends
Other preferred stock dividends 17.58M 94.11M
Net income attributable to common stockholders 204.48%5.46M 153.14%4.35M -1,118.38%-121.29M 24.28%-31.54M 16.75%-8.17M -263.78%-5.23M 36.91%-8.19M 54.85%-9.96M 50.63%-41.66M 48.89%-9.81M
Basic earnings per share 103.65%0.98 817.97%1.01K 30.88%-141 89.28%-114 95.92%-10.1878 -132.88%-26.83 57.51%-140.73 63.83%-204 55.49%-1.06K 46.16%-249.4
Diluted earnings per share 89.45%-2.83 -2,299.49%-3.38K 30.88%-141 89.28%-114 95.92%-10.1878 -132.88%-26.83 57.51%-140.73 63.83%-204 55.49%-1.06K 46.16%-249.4
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Heat List
US
Overall
Symbol
Price
% Chg

No Data